Article Details
Retrieved on: 2025-10-06 17:21:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Both drug candidates are built on GT Biopharma's proprietary TriKE platform, which uses specialized antibody fragments originally discovered in camels ...
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here